BBLG Q3 2025 Earnings — Bone Biologics Corporation Revenue & Financial Results | Market Cap Arena

BBLGBone Biologics Corporation

$2M

Q3 2025 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$715,274

Net Income

-$666,737

EPS (Diluted)

$-0.37

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$591,384

Free Cash Flow

-$591,384

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$6M

Total Liabilities

$334,282

Stockholders' Equity

$6M

Cash & Equivalents

$6M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$715,274	-$951,021	+24.8%
Net Income	-$666,737	-$941,002	+29.1%